Trifluoromethyl group as a pharmacophore: Effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand

作者: Raj Betageri , Yan Zhang , Renee M. Zindell , Daniel Kuzmich , Thomas M. Kirrane

DOI: 10.1016/J.BMCL.2005.07.025

关键词:

摘要: Compound 1, a potent glucocorticoid receptor ligand, contains quaternary carbon bearing trifluoromethyl and hydroxyl groups. This paper describes the effect of replacing group on binding agonist activity GR ligand 1. The results illustrate that CF3 with cyclohexylmethyl or benzyl maintains potency. These substitutions alter functional behavior ligands from agonists to antagonists. Docking studies suggest analog 19 binds in similar fashion as antagonist, RU486. central C-11 dimethylaniline moiety RU486 overlay. Binding compound is believed force helix 12 adopt an open conformation this leads antagonist properties non-CF3 carrying large at center molecule.

参考文章(34)
Jeffrey C Webster, John A Cidlowski, Mechanisms of Glucocorticoid-receptor-mediated Repression of Gene Expression Trends in Endocrinology and Metabolism. ,vol. 10, pp. 396- 402 ,(1999) , 10.1016/S1043-2760(99)00186-1
Bethany D Jenkins, Christian B Pullen, Beatrice D Darimont, Novel glucocorticoid receptor coactivator effector mechanisms Trends in Endocrinology & Metabolism. ,vol. 12, pp. 122- 126 ,(2001) , 10.1016/S1043-2760(00)00357-X
Lin Zhi, Christopher M. Tegley, E. Adam Kallel, Keith B. Marschke, Dale E. Mais, Marco M. Gottardis, Todd K. Jones, 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists. Journal of Medicinal Chemistry. ,vol. 41, pp. 291- 302 ,(1998) , 10.1021/JM9705768
Lin Zhi, Christopher M Tegley, James P Edwards, Sarah J West, Keith B Marschke, Marco M Gottardis, Dale E Mais, Todd K Jones, 5-Alkyl 1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. ,vol. 8, pp. 3365- 3370 ,(1998) , 10.1016/S0960-894X(98)00608-8
Amjad Ali, Christopher F. Thompson, James M. Balkovec, Donald W. Graham, Milton L. Hammond, Nazia Quraishi, James R. Tata, Monica Einstein, Lan Ge, Georgianna Harris, Terri M. Kelly, Paul Mazur, Shilpa Pandit, Joseph Santoro, Ayesha Sitlani, Chuanlin Wang, Joanne Williamson, Douglas K. Miller, Chris M. Thompson, Dennis M. Zaller, Michael J. Forrest, Ester Carballo-Jane, Silvi Luell, Novel N-Arylpyrazolo[3,2-c]-Based Ligands for the Glucocorticoid Receptor: Receptor Binding and in Vivo Activity Journal of Medicinal Chemistry. ,vol. 47, pp. 2441- 2452 ,(2004) , 10.1021/JM030585I
Ian M. Adcock, Molecular mechanisms of glucocorticosteroid actions. Pulmonary Pharmacology & Therapeutics. ,vol. 13, pp. 115- 126 ,(2000) , 10.1006/PUPT.2000.0243
A. Mukherjee, L. Kirkovsky, X. T. Yao, R. C. Yates, D. D. Miller, J. T. Dalton, Enantioselective binding of Casodex to the androgen receptor Xenobiotica. ,vol. 26, pp. 117- 122 ,(1996) , 10.3109/00498259609046693
François Tronche, Christoph Kellendonk, Holger M Reichardt, Günther Schütz, Genetic Dissection of Glucocorticoid Receptor Function in Mice Current Opinion in Genetics & Development. ,vol. 8, pp. 532- 538 ,(1998) , 10.1016/S0959-437X(98)80007-5
Randy K. Bledsoe, Valerie G. Montana, Thomas B. Stanley, Chris J. Delves, Christopher J. Apolito, David D. McKee, Thomas G. Consler, Derek J. Parks, Eugene L. Stewart, Timothy M. Willson, Millard H. Lambert, John T. Moore, Kenneth H. Pearce, H.Eric Xu, Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition Cell. ,vol. 110, pp. 93- 105 ,(2002) , 10.1016/S0092-8674(02)00817-6
Björn Kauppi, Clarissa Jakob, Mathias Färnegårdh, Jie Yang, Harri Ahola, Maria Alarcon, Karin Calles, Owe Engström, John Harlan, Steven Muchmore, Anna-Karin Ramqvist, Susanne Thorell, Lars Öhman, Jonathan Greer, Jan-Åke Gustafsson, Jan Carlstedt-Duke, Mats Carlquist, The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain RU-486 INDUCES A TRANSCONFORMATION THAT LEADS TO ACTIVE ANTAGONISM Journal of Biological Chemistry. ,vol. 278, pp. 22748- 22754 ,(2003) , 10.1074/JBC.M212711200